WBC
WST icon

West Branch Capital’s West Pharmaceutical WST Stock Holding History

West Branch Capital’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-80
Closed -$22K – 431
2025
Q4 		$22K Hold
80
– – 0.01% 187
2025
Q3 		$21K Hold
80
– – 0.01% 207
2025
Q2 		$17.5K Sell
80
-25
-24% -$5.34K 0.01% 220
2025
Q1 		$23.5K Hold
105
– – 0.01% 209
2024
Q4 		$34.4K Hold
105
– – 0.01% 179
2024
Q3 		$31.5K Hold
105
– – 0.01% 189
2024
Q2 		$34.6K Hold
105
– – 0.01% 181
2024
Q1 		$41.5K Hold
105
– – 0.02% 170
2023
Q4 		$37K Hold
105
– – 0.02% 180
2023
Q3 		$39.4K Hold
105
– – 0.02% 173
2023
Q2 		$40.2K Hold
105
– – 0.02% 176
2023
Q1 		$36.4K Hold
105
– – 0.02% 191
2022
Q4 		$24.7K Hold
105
– – 0.02% 209
2022
Q3 		$26K Hold
105
– – 0.02% 208
2022
Q2 		$32K Hold
105
– – 0.02% 200
2022
Q1 		$43K Hold
105
– – 0.02% 197
2021
Q4 		$49K Hold
105
– – 0.02% 199
2021
Q3 		$45K Hold
105
– – 0.02% 193
2021
Q2 		$38K Buy
+105
New +$34.7K 0.02% 213

Other funds holding WST

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

West Branch Capital's WST Position: Q1 2026 in Review

West Branch Capital sold out of West Pharmaceutical (WST) in Q1 2026, closing a stake of 80 shares — an estimated $22K sold.

West Branch Capital first reported a position in WST in Q2 2021 and held it in 19 quarters. The position peaked at $49K in Q4 2021. 753 funds tracked by Wall St. Rank hold WST as of Q1 2026.

  • West Branch Capital reported no remaining West Pharmaceutical position as of Q1 2026 after selling out during the quarter.
  • West Branch Capital sold 80 West Pharmaceutical shares in Q1 2026, an estimated $22K.
  • West Branch Capital first reported a position in West Pharmaceutical in Q2 2021 and held it in 19 quarters.
  • West Branch Capital's West Pharmaceutical position peaked at $49K in Q4 2021.
  • 753 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2026.

Based on West Branch Capital's 13F filing for Q1 2026, filed 14 Apr 2026.